Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debopam Samanta

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Journal of Child Neurology|June 2, 2026
First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective CohortHannah Lewis, Alexandra Kiss, Praveen Ramani, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|March 26, 2026
Magnetoencephalography as a Novel Tool for Prenatal Diagnosis of Fetal SeizuresDayna D Whitcombe, Diana Escalona-Vargas, Hari Eswaran, et al.
Developmental Neuroscience|September 1, 2021
Nonsyndromic Early-Onset Epileptic Encephalopathies: Two Novel KCTD7 Pathogenic Variants and a Literature ReviewSima Binaafar, Masoud Garshasbi, Ali Reza Tavasoli, et al.
Journal of Child Neurology|March 21, 2022
Physicians' Perspectives on Presurgical Discussion and Shared Decision-Making in Pediatric Epilepsy SurgeryDebopam Samanta, Adam P Ostendorf, Rani Singh, et al.
Epilepsy Research|March 13, 2024
Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]Joseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Epilepsy Research|March 4, 2023
Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsyJoseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Plos One|June 12, 2025
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Agnies M van Eeghen, Elizabeth A Thiele, Sam Amin, et al.
Epilepsy & Behavior : E&B|October 11, 2024
Neuromodulation strategies in developmental and epileptic encephalopathiesDebopam Samanta, Zulfi Haneef, Gregory W Albert, et al.
Children (Basel, Switzerland)|October 27, 2022
SCN1B Genetic Variants: A Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic EncephalopathyZahra Zhu, Elizabeth Bolt, Kyra Newmaster, et al.
Epilepsia|February 13, 2025
Evaluating the effectiveness of medical therapy in infantile epileptic spasms syndrome due to surgically-remediable lesionsAvantika Singh, Aristides Hadjinicolaou, Christina Briscoe-Abath, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Journal of Child Neurology|June 2, 2026
First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective CohortHannah Lewis, Alexandra Kiss, Praveen Ramani, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|March 26, 2026
Magnetoencephalography as a Novel Tool for Prenatal Diagnosis of Fetal SeizuresDayna D Whitcombe, Diana Escalona-Vargas, Hari Eswaran, et al.
Developmental Neuroscience|September 1, 2021
Nonsyndromic Early-Onset Epileptic Encephalopathies: Two Novel KCTD7 Pathogenic Variants and a Literature ReviewSima Binaafar, Masoud Garshasbi, Ali Reza Tavasoli, et al.
Journal of Child Neurology|March 21, 2022
Physicians' Perspectives on Presurgical Discussion and Shared Decision-Making in Pediatric Epilepsy SurgeryDebopam Samanta, Adam P Ostendorf, Rani Singh, et al.
Epilepsy Research|March 13, 2024
Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]Joseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Epilepsy Research|March 4, 2023
Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsyJoseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Plos One|June 12, 2025
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)Agnies M van Eeghen, Elizabeth A Thiele, Sam Amin, et al.
Epilepsy & Behavior : E&B|October 11, 2024
Neuromodulation strategies in developmental and epileptic encephalopathiesDebopam Samanta, Zulfi Haneef, Gregory W Albert, et al.
Children (Basel, Switzerland)|October 27, 2022
SCN1B Genetic Variants: A Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic EncephalopathyZahra Zhu, Elizabeth Bolt, Kyra Newmaster, et al.
Epilepsia|February 13, 2025
Evaluating the effectiveness of medical therapy in infantile epileptic spasms syndrome due to surgically-remediable lesionsAvantika Singh, Aristides Hadjinicolaou, Christina Briscoe-Abath, et al.
Pageof 17